Dr Reddys Laboratories (RDY) Profit After Tax (QoQ) (2009 - 2023)
Dr Reddys Laboratories (RDY) Profit After Tax (QoQ) (2009 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.86 Bn | 88.00 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.98 Bn | 32.24 Bn | 1.97 Bn |
| 3 | Zoetis | 32.48 Bn | 30.54 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.01 Bn | 20.86 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.02 Bn | 22.02 Bn | - |
| 7 | Viatris | 20.40 Bn | 18.59 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.46 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.74 Bn | 12.31 Bn | 785.00 Mn |
| 10 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -1.16% |
| Mar 31, 2023 | 47.01% |
| Dec 31, 2022 | 76,973,584.21% |
| Jun 30, 2021 | 74.03% |
| Sep 30, 2020 | -175.00% |
| Jun 30, 2020 | 31.65% |
| Sep 30, 2019 | -55.56% |
| Jun 30, 2019 | 30.77% |
| Mar 31, 2019 | 85.71% |
| Dec 31, 2018 | -10.00% |
| Sep 30, 2018 | 6.06% |
| Jun 30, 2018 | 4.76% |
| Mar 31, 2018 | 43.18% |
| Dec 31, 2017 | -16.98% |
| Dec 31, 2016 | -74.42% |
| Mar 31, 2016 | 45.31% |
| Dec 31, 2015 | -26.44% |
| Sep 30, 2015 | -20.91% |
| Dec 31, 2014 | -21.43% |
| Mar 31, 2014 | -3.16% |